FDA Awards Priority Review Voucher to Sponsor of Rare Pediatric Disease Product Viltolarsen

Summary

The FDA has issued a priority review voucher to NS Pharma Inc., the manufacturer of viltolarsen, a rare pediatric disease product, following a review of its application under the FD&C Act and FDASIA.